Skip to main content Skip to section navigation Skip to footer
Partnering Careers
IMV Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • DPX Delivery Platform
    • Overview
    • Scientific Materials
  • Pipeline
    • Overview
    • Maveropepimut-S
    • Expanded Access
  • News & Media
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contacts
    • FAQ
  • Contact
    • Get in Touch
    • Safety & Respect
  • Partnering
  • Careers

Press Releases

News & Media

News & Media

  • Press Releases
  • Events
  • Email Alerts
Feb 02, 2010 6:00pm EST

Immunovaccine Hires Investor Relations Firm

Jan 28, 2010 6:00pm EST

Immunovaccine Grants Stock Options

Dec 09, 2009 8:45am EST

Immunovaccine Receives Clearance From FDA to Proceed With Phase 1 Clinical Trial for Its Therapeutic Cancer Vaccine

Nov 23, 2009 8:45am EST

Immunovaccine Licenses Vaccine Platform to Pfizer Animal Health

Nov 10, 2009 8:45am EST

Immunovaccine Inc. Signs Collaboration Agreement with National Cancer Institute

Nov 02, 2009 2:33pm EST

Immunovaccine Inc. Signs Cato Research Canada, Inc. as Clinical Trial CRO

Oct 29, 2009 9:10am EDT

Immunovaccine Expands Collaboration with Defence Research & Development Canada

Oct 22, 2009 4:22pm EDT

Immunovaccine Inc. Revises Escrow Securities Schedule

Oct 05, 2009 9:38am EDT

Immunovaccine Inc. Begins Trading on the TSX-V Under the Symbol "IMV"

  • Previous Pagearrow_back
  • Page 1…
  • Page 39
  • Page 40
  • Page 41
  • Page 42
rss_feed News RSS
  • Visit us on Twitter

    Twitter

  • Visit us on LinkedIn

    LinkedIn

  • Visit us on Youtube

    Youtube

© IMV Inc. All Rights Reserved.
Privacy Policy Terms of Use Sitemap Manage Cookie Preferences